Kimberly J Popovits

Director · 3 filings · Latest: May 29, 2026

EXACT SCIENCES CORP

Kiniksa Pharmaceuticals International, plc

RHYTHM PHARMACEUTICALS, INC.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KNSA	Kimberly J Popovits	Director	May 29, 2026	Option Exercise	—	2,799	—	15,345	Jun 2 4:51 PM
EXAS	Kimberly J Popovits	Director	Mar 23, 2026	Disposition	—	16,381	—	0	Mar 23 9:18 AM